The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure

Psychopharmacology

Volumn 126, Issue 1, 1996, Pages 42-49

  Powell, Kelly R ^a,c,d   Dykstra, Linda A ^a,b,d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antinociception; Morphine; Serotonin; Shock titration; Squirrel monkeys

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA 2 ADRENERGIC RECEPTOR; BEMESETRON; CLONIDINE; IPSAPIRONE; KETANSERIN; MORPHINE; MU OPIATE RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; YOHIMBINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ELECTRIC SHOCK; MALE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; SQUIRREL MONKEY; TAIL FLICK TEST;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; MALE; MORPHINE; PAIN MEASUREMENT; PYRIMIDINES; RECEPTORS, OPIOID, MU; RECEPTORS, SEROTONIN; SAIMIRI; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0029970968     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246409     Document Type: Article

References (62)

1. 1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 265: 378-385
2. Craft RM, Dykstra LA (1990) Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule. J Pharmacol Exp Ther 252: 945-952
3. Crisp T, Stafinsky JL, Uram M, Perni VC, Weaver MF, Spanos LJ (1991) Serotonin contributes to the spinal antinociceptive effects of morphine. Pharmacol Biochem Behav 39: 591-595
4. Cui Y, Lee TF, Kramarova LI, Wang LCH (1993) The modulatory effects of mu and kappa opioid agonists on 5-HT release from hippocampal slices of euthermic and hibernating ground squirrels. Life Sci 53: 1957-1965
5. Danzebrink RM, Gebhart GF (1991) Intrathecal coadministration of clonidine with serotonin receptor agonists produces supraadditive visceral antinociception in the rat. Brain Res 555: 35-42
6. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254: 245-252
7. Dykstra LA, Massie CA (1988) Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey. J Pharmacol Exp Ther 246: 813-821
8. 2 analysis. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin, pp 107-121
9. 1A antagonists BMY 7378, NAN-190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats. J Pharmacol Exp Ther 270: 1359-1366
10. Fozard JR (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. NaunynSchmiedeberg's Arch Pharmacol 326: 36-44
11. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 154: 339-341
12. Gordon WP, Cheng H, Larsen DL, Ragner JA, Landmesser NG (1992) Identification of urinary metabolites of 8-methyl-8-azabicyclo-[3.2.1]octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey. Drug Metab Dispos 20: 596-602
13. 1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the dorsal raphe nucleus in vitro. Eur J Pharmacol 211: 211-219
14. 3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur J Pharmacol 164: 315-322
15. 2- adrenergic mechanisms in non-human primates. Brain Res 410: 353-356
16. Ho BY, Takemori AE (1989) Serotonergic involvement in the antinociceptive action and the development of tolerance to the kappa-opioid receptor agonist, U-50,488H. J Pharmacol Exp Ther 508-514
17. 3H]ketanserin. Eur J Pharmacol 118: 13-23
18. 1B recognition sites. Brain Res 376: 85-96
19. 1-adrenoceptors in human and pig brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 335: 226-230
20. Kalso EA, Sullivan AF, McQuay HJ, Dickenson AH. Roques BP (1993) Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat. J Pharmacol Exp Ther 265: 551-558
21. Kellstein DE, Malseed RT, Goldstein FJ (1988) Opioid-monoamine interactions in spinal antinociception: evidence for serotonin but not norepinephrine reciprocity. Pain 34: 85-92
22. Kiefel JM, Cooper ML, Bodnar RJ (1992) Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res 597: 331-338
23. Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39-100
24. Kunihara M, Ohyama M, Nakano M (1992) Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective k-opioid agonist. Eur J Pharmacol 214: 111-118
25. 2-receptors in rat brain. Eur J Pharmacol 81: 43-48
26. Langer SZ, Cavero I, Massingham R (1980) Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hypertension 2: 372-382
27. 2 receptors. Life Sci 28: 1015-1022
28. 2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprical 5-HT-dopamine interaction. Psychopharmacology 97: 456-461
29. Lin MT, Lee JM, Cheng JT (1987) Changes in central serotonergic transmission affect clonidine analgesia in monkeys. Naunyn-Schmiedeberg's Arch Pharmacol 335: 491-495
30. Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol 319: 197-205
31. Matos FF, Rollema H, Brown JL, Basbaum AI (1992) Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat. Pain 48: 439-447
32. 2-adrenoreceptor antagonism. Neuropharmacology 22: 775-779
33. McKearney JW (1989) Apparent antinociceptive properties of piperazine-type serotonin agonists: trifluoromethylphenylpiperazine, chlorophenyl-piperazine, and MK-212. Pharmacol Biochem Behav 32: 657-660
34. McKearney JW (1990) Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluorophenylpiperazine, and chlorophenylpiperazine. Pharmacol Biochem Behav 35: 181-185
35. 1 recognition sites. Eur J Pharmacol 90: 151-153
36. 1A partial agonists in the rat. Neuropharmacology 29: 315-318
37. 1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner. J Pharmacol Exp Ther 256: 983-992
38. 1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats. J Pharmacol Exp Ther 256: 993-1001
39. 1A antagonists. J Pharmacol Exp Ther 268: 337-352
40. Minor BG, Archer T, Post C, Jonsson G, Mohammed AK (1986) 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats. J Neural Transm 66: 243-259
41. Mohrland JS, Gebhart GF (1980) Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception. Life Sci 27: 2627-2632
42. Monroe PJ, Perschke SE, Crisp T, Smith DJ (1991) Evaluation of the interactions of serotonergic and adrenergic drugs with μ, ∂ and k opioid binding sites. Neurosci Lett 133: 229-232
43. Nakagawa I, Omote K, Kitahata LM, Collins JG, Murata K (1990) Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems. Anesthesiology 73: 474-478
44. 2 receptor: structurally specific differentiation by ergolines and tryptamines. J Pharmacol Exp Ther 265: 1272-1279
45. Passarelli, F, Costa T (1989) Mu and delta opioid receptors inhibit serotonin release in rat hippocampus. J Pharmacol Exp Ther 248: 299-305
46. 2 antagonists, pirenperone and ketanserin. Pharmacol Biochem Behav 31: 641-647
47. Pazos A, Cortes R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346: 231-249
48. Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123-139
49. 1A receptors. Biol Psychiatry 20: 971-979
50. Powell KR, Dykstra LA (1995a) The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure. I. Kappa opioids. J Pharmacol Exp Ther 274: 1305-1316
51. Powell KR, Dykstra LA (1995b) Serotonergic modulation of the antinociceptive effects of mu and kappa opioids in squirrel monkeys. Analgesia 1: 659-662
52. Smith JB (1985) Effects of single and repeated daily injections of morphine, clonidine and l-nantradol on responding of squirrel monkeys under escape titration. J Pharmacol Exp Ther 234: 94-99
53. Solomon RE, Gebhart GF (1988) Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. J Pharmacol Exp Ther 245: 905-912
54. Stevens CW, Monasky MS, Yaksh TL (1988) Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. J Pharmacol Exp Ther 244: 63-70
55. Vasko MR, Pang I-H, Vogt M (1984) Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord. Brain Res 306: 341-348
56. VonVoigtlander PF, Lewis RA (1982) U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Prog Neuropsychopharmacol Biol Psychiatry 6: 467-470
57. VonVoigtlander PF, Lahti RA, Ludens JH (1983) U-50,488: a selective structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224: 7-12
58. VonVoigtlander PF Lewis RA, Neff GL (1984) Kappa opioid analgesia is dependent on serotonergic mechanisms. J Pharmacol Exp Ther 231:270-274
59. 3 receptors in mouse CNS. Eur J Pharmacol 151: 351-352
60. 1A receptor agonist, 8-OH-DPAT? Eur J Pharmacol 193: 253-256
61. Yaksh TL (1979) Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 160: 180-185
62. Yaksh TL, Tyce GM (1979) Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res 171: 176-181